Literature DB >> 28117020

Membrane-active Antimicrobial Peptides as Template Structures for Novel Antibiotic Agents.

Karl Lohner1.   

Abstract

The increase of pathogens being resistant to antibiotics represents a global health problem and therefore it is a pressing need to develop antibiotics with novel mechanisms of action. Host defense peptides, which have direct antimicrobial activity (also termed antimicrobial peptides) or immune modulating activity, are valuable template structures for the development of such compounds. Antimicrobial peptides exhibit remarkably different structures as well as biological activity profiles with multiple targets. A large fraction of these peptides interfere physically with the cell membrane of bacteria (focus of this review), but can also translocate into the cytosol, where they interact with nucleic acids, ribosomes and proteins. Several potential interaction sites have to be considered on the route of the peptides from the environment to the cytoplasmic membrane. Translocation of peptides through the cell wall may not be impaired by the thick but relatively porous peptidoglycan layer. However, interaction with lipopolysaccharides of the outer membrane of Gram-negative bacteria and (lipo)teichoic acids of Gram-positive bacteria may reduce the effective concentration at the cytoplasmic membrane, where supposedly the killing event takes place. On a molecular level several mechanisms are discussed, which are important for the rational design of improved antimicrobial compounds: toroidal pore formation, carpet model (coverage of membrane surface by peptides), interfacial activity, void formation, clustering of lipids and effects of membrane curvature. In summary, many of these models just represent special cases that can be interrelated to each other and depend on both the nature of lipids and peptides.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28117020

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  26 in total

1.  Adevonin, a novel synthetic antimicrobial peptide designed from the Adenanthera pavonina trypsin inhibitor (ApTI) sequence.

Authors:  Mayara S Rodrigues; Caio F R de Oliveira; Luís H O Almeida; Simone M Neto; Ana Paula A Boleti; Edson L Dos Santos; Marlon H Cardoso; Suzana M Ribeiro; Octávio L Franco; Fernando S Rodrigues; Alexandre J Macedo; Flávia R Brust; Maria Lígia R Macedo
Journal:  Pathog Glob Health       Date:  2018-12-20       Impact factor: 2.894

2.  Lactoferricins impair the cytosolic membrane of Escherichia coli within a few seconds and accumulate inside the cell.

Authors:  Enrico F Semeraro; Lisa Marx; Johannes Mandl; Ilse Letofsky-Papst; Claudia Mayrhofer; Moritz P K Frewein; Haden L Scott; Sylvain Prévost; Helmut Bergler; Karl Lohner; Georg Pabst
Journal:  Elife       Date:  2022-06-07       Impact factor: 8.713

3.  What Makes a Good Pore Former: A Study of Synthetic Melittin Derivatives.

Authors:  Aliasghar Sepehri; Leo PeBenito; Almudena Pino-Angeles; Themis Lazaridis
Journal:  Biophys J       Date:  2020-03-03       Impact factor: 4.033

4.  NP108, an Antimicrobial Polymer with Activity against Methicillin- and Mupirocin-Resistant Staphylococcus aureus.

Authors:  Derry K Mercer; Laura K Katvars; Fiona Hewitt; Daniel W Smith; Jennifer Robertson; Deborah A O'Neil
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

5.  The Semi-Synthetic Peptide Lin-SB056-1 in Combination with EDTA Exerts Strong Antimicrobial and Antibiofilm Activity against Pseudomonas aeruginosa in Conditions Mimicking Cystic Fibrosis Sputum.

Authors:  Giuseppantonio Maisetta; Lucia Grassi; Semih Esin; Ilaria Serra; Mariano A Scorciapino; Andrea C Rinaldi; Giovanna Batoni
Journal:  Int J Mol Sci       Date:  2017-09-16       Impact factor: 5.923

6.  Buwchitin: A Ruminal Peptide with Antimicrobial Potential against Enterococcus faecalis.

Authors:  Linda B Oyama; Jean-Adrien Crochet; Joan E Edwards; Susan E Girdwood; Alan R Cookson; Narcis Fernandez-Fuentes; Kai Hilpert; Peter N Golyshin; Olga V Golyshina; Florence Privé; Matthias Hess; Hilario C Mantovani; Christopher J Creevey; Sharon A Huws
Journal:  Front Chem       Date:  2017-07-12       Impact factor: 5.221

7.  Designing Antibacterial Peptides with Enhanced Killing Kinetics.

Authors:  Faiza H Waghu; Shaini Joseph; Sanket Ghawali; Elvis A Martis; Taruna Madan; Kareenhalli V Venkatesh; Susan Idicula-Thomas
Journal:  Front Microbiol       Date:  2018-02-23       Impact factor: 5.640

8.  Antimicrobial Activity and Cell Selectivity of Synthetic and Biosynthetic Cationic Polymers.

Authors:  Mayandi Venkatesh; Veluchamy Amutha Barathi; Eunice Tze Leng Goh; Raditya Anggara; Mobashar Hussain Urf Turabe Fazil; Alice Jie Ying Ng; Sriram Harini; Thet Tun Aung; Stephen John Fox; Shouping Liu; Liang Yang; Timothy Mark Sebastian Barkham; Xian Jun Loh; Navin Kumar Verma; Roger W Beuerman; Rajamani Lakshminarayanan
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

9.  Cathelicidin and PMB neutralize endotoxins by multifactorial mechanisms including LPS interaction and targeting of host cell membranes.

Authors:  Andra B Schromm; Laura Paulowski; Yani Kaconis; Franziska Kopp; Max Koistinen; Annemarie Donoghue; Susanne Keese; Christian Nehls; Julia Wernecke; Patrick Garidel; Eva Sevcsik; Karl Lohner; Susana Sanchez-Gomez; Guillermo Martinez-de-Tejada; Klaus Brandenburg; Mario Brameshuber; Gerhard J Schütz; Jörg Andrä; Thomas Gutsmann
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-06       Impact factor: 11.205

10.  Synergism of Antimicrobial Frog Peptides Couples to Membrane Intrinsic Curvature Strain.

Authors:  Regina Leber; Michael Pachler; Ivo Kabelka; Irene Svoboda; Daniel Enkoller; Robert Vácha; Karl Lohner; Georg Pabst
Journal:  Biophys J       Date:  2018-04-24       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.